These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 26198245)
1. Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome. Legeay S; Rodier M; Fillon L; Faure S; Clere N Nutrients; 2015 Jul; 7(7):5443-68. PubMed ID: 26198245 [TBL] [Abstract][Full Text] [Related]
2. The potential role of green tea catechins in the prevention of the metabolic syndrome - a review. Thielecke F; Boschmann M Phytochemistry; 2009 Jan; 70(1):11-24. PubMed ID: 19147161 [TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin gallate and mitochondria-A story of life and death. Oliveira MR; Nabavi SF; Daglia M; Rastrelli L; Nabavi SM Pharmacol Res; 2016 Feb; 104():70-85. PubMed ID: 26731017 [TBL] [Abstract][Full Text] [Related]
4. In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3- Saeki K; Hayakawa S; Nakano S; Ito S; Oishi Y; Suzuki Y; Isemura M Molecules; 2018 May; 23(6):. PubMed ID: 29843451 [TBL] [Abstract][Full Text] [Related]
5. Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate. Keske MA; Ng HL; Premilovac D; Rattigan S; Kim JA; Munir K; Yang P; Quon MJ Curr Med Chem; 2015; 22(1):59-69. PubMed ID: 25312214 [TBL] [Abstract][Full Text] [Related]
6. Mechanisms underlying beneficial health effects of tea catechins to improve insulin resistance and endothelial dysfunction. Kim JA Endocr Metab Immune Disord Drug Targets; 2008 Jun; 8(2):82-8. PubMed ID: 18537694 [TBL] [Abstract][Full Text] [Related]
7. The challenge of developing green tea polyphenols as therapeutic agents. Huo C; Wan SB; Lam WH; Li L; Wang Z; Landis-Piwowar KR; Chen D; Dou QP; Chan TH Inflammopharmacology; 2008 Oct; 16(5):248-52. PubMed ID: 18815735 [TBL] [Abstract][Full Text] [Related]
8. Effects of green tea and EGCG on cardiovascular and metabolic health. Wolfram S J Am Coll Nutr; 2007 Aug; 26(4):373S-388S. PubMed ID: 17906191 [TBL] [Abstract][Full Text] [Related]
9. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate. James KD; Forester SC; Lambert JD Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115 [TBL] [Abstract][Full Text] [Related]
10. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Potenza MA; Marasciulo FL; Tarquinio M; Tiravanti E; Colantuono G; Federici A; Kim JA; Quon MJ; Montagnani M Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1378-87. PubMed ID: 17227956 [TBL] [Abstract][Full Text] [Related]
11. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo. Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482 [TBL] [Abstract][Full Text] [Related]
12. Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Kwon OS; Han JH; Yoo HG; Chung JH; Cho KH; Eun HC; Kim KH Phytomedicine; 2007 Aug; 14(7-8):551-5. PubMed ID: 17092697 [TBL] [Abstract][Full Text] [Related]
13. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice. Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799 [TBL] [Abstract][Full Text] [Related]
14. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex. Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757 [TBL] [Abstract][Full Text] [Related]
15. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases. Benelli R; Venè R; Bisacchi D; Garbisa S; Albini A Biol Chem; 2002 Jan; 383(1):101-5. PubMed ID: 11928805 [TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Ahn HY; Xu Y; Davidge ST Life Sci; 2008 Apr; 82(17-18):964-8. PubMed ID: 18397796 [TBL] [Abstract][Full Text] [Related]
17. Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats. Liu Y; Zhang D; Wang Y; Zhang W; Liu X Xenobiotica; 2018 Apr; 48(4):412-421. PubMed ID: 28471331 [TBL] [Abstract][Full Text] [Related]
18. Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria. Weng Z; Zhou P; Salminen WF; Yang X; Harrill AH; Cao Z; Mattes WB; Mendrick DL; Shi Q Biochem Biophys Res Commun; 2014 Jan; 443(3):1097-104. PubMed ID: 24384371 [TBL] [Abstract][Full Text] [Related]
19. Pleiotropic beneficial effects of epigallocatechin gallate, quercetin and delphinidin on cardiovascular diseases associated with endothelial dysfunction. Dayoub O; Andriantsitohaina R; Clere N Cardiovasc Hematol Agents Med Chem; 2013 Dec; 11(4):249-64. PubMed ID: 24617305 [TBL] [Abstract][Full Text] [Related]
20. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery. Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]